Latest filing published 27 Oct 2026 for Cutia Therapeutics - B.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -33.5%Entry HK$9.41 · Close at T+365 HK$6.26
- -33.2%Entry HK$12.30 · Close at T+365 HK$8.22
- -29.7%Entry HK$12.00 · Close at T+365 HK$8.43
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Zhang Lele: trading record in brief
Zhang Lele discloses dealings in 2 companies, chiefly Cutia Therapeutics - B and Touyun Biotech Group Ltd. The record holds 28 filings, for trades running from 12 June 2023 to 26 October 2026.
In open-market terms, that means 5 purchases worth €45k on one side and 17 sales worth €473k on the other. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at no purchases and 17 sales.
In size, the median ticket on the buying side is €8,830. Of 4 purchases, 3 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. After 4 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -59.7%. They describe history only and say nothing certain about the share price ahead.
Most recently, on 27 October 2026, the filings show a transaction in Cutia Therapeutics - B. The last insider purchase was made public on 8 November 2024, 731 days ago. Filings reach the HKEX feed a median of 4 days after the trade. This delay matters because a trade only becomes useful information once it is public. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from HKEX. Past trades are no guide to future returns.
Companies and markets linked to Zhang Lele
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,803,555 shares0ShareXHKGHKEX:DA20261027E00089
- 91,000 shares@ HK$0.81780.024% mcap1.8% of flowShareXHKGHKEX:DA20261016E00408
- 671,600 shares@ HK$0.6260.14% mcap10.1% of flowShareXHKGHKEX:DA20261016E00413
- 1,173,000 shares@ HK$0.67680.26% mcap19.1% of flowShareXHKGHKEX:DA20261016E00412
- 118,200 shares@ HK$0.75110.029% mcap2.1% of flowShareXHKGHKEX:DA20261016E00411
- 90,400 shares@ HK$0.79220.023% mcap1.7% of flowShareXHKGHKEX:DA20261016E00410
- 68,200 shares@ HK$0.82150.018% mcap1.3% of flowShareXHKGHKEX:DA20261016E00409
- 258,600 shares@ HK$0.90550.073% mcap8.8% of flowShareXHKGHKEX:DA20261009E00554
- 229,600 shares@ HK$0.97610.070% mcap8.4% of flowShareXHKGHKEX:DA20261009E00552
- 130,600 shares@ HK$0.88890.036% mcap4.4% of flowShareXHKGHKEX:DA20261009E00555
- 81,400 shares@ HK$0.94990.024% mcap2.9% of flowShareXHKGHKEX:DA20261009E00553
- 91,000 shares@ HK$0.95970.023% mcap8.6% of flowShareXHKGHKEX:DA20260930E00363
- 1,302,800 shares@ HK$0.77840.27% mcap49.9% of flowShareXHKGHKEX:DA20260930E00368
- 653,800 shares@ HK$1.0070.21% mcap15.6% of flowShareXHKGHKEX:DA20260925E00252
- 113,400 shares@ HK$1.0640.039% mcap2.8% of flowShareXHKGHKEX:DA20260925E00243
- 136,800 shares@ HK$1.08420.047% mcap3.5% of flowShareXHKGHKEX:DA20260925E00207
- 5,200 shares@ HK$1.17920.0020% mcap0.1% of flowShareXHKGHKEX:DA20260924E00610
- 200 shares@ HK$1.200.0001% mcap0.0% of flowShareXHKGHKEX:DA20260924E00609
- 187,500 shares0ShareXHKGHKEX:DA20260703E00308
- 2,499,519 sharesShareXHKGHKEX:DA20251106E00413
- 9,000,000 sharesShareXHKGHKEX:DA20241115E00361
- 1,157,500 sharesShareXHKGHKEX:DA20241108E00300
- 5,000 shares@ HK$9.8561.1% of flowShareXHKGHKEX:DA20241108E00301Canonical exit: 6 Feb 2025 (T+90)
- 5,000 shares@ HK$11.9321.4% of flowShareXHKGHKEX:DA20241016E00399Canonical exit: 14 Jan 2025 (T+90)
- 15,000 shares@ HK$12.09714.1% of flowShareXHKGHKEX:DA20241016E00397Canonical exit: 13 Jan 2025 (T+90)
25 of 28 declarations